Deutsche Bank Ag\ Mannkind Corp Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Mannkind Corp stock. As of the latest transaction made, Deutsche Bank Ag\ holds 435,720 shares of MNKD stock, worth $2.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

435,720

Previous 401,534 8.51%

Holding current value

$2.59 Million

Previous $2.1 Million 30.53%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$5.01 - $6.7 $171,271 - $229,046	34,186 Added 8.51%	435,720 $2.74 Million
Q2 2024 Aug 14, 2024	SELL	$4.05 - $5.43 $76,998 - $103,235	-19,012 Reduced 4.52%	401,534 $2.1 Million
Q1 2024 May 15, 2024	BUY	$3.25 - $5.27 $81,133 - $131,560	24,964 Added 6.31%	420,546 $1.91 Million
Q4 2023 Feb 14, 2024	BUY	$3.34 - $4.29 $865,838 - $1.11 Million	259,233 Added 190.12%	395,582 $1.44 Million
Q3 2023 Nov 09, 2023	BUY	$3.91 - $5.45 $81,937 - $114,210	20,956 Added 18.16%	136,349 $563,000
Q2 2023 Aug 14, 2023	SELL	$3.72 - $4.79 $994,720 - $1.28 Million	-267,398 Reduced 69.85%	115,393 $469,000
Q1 2023 May 15, 2023	BUY	$3.95 - $5.63 $182,383 - $259,953	46,173 Added 13.72%	382,791 $1.57 Million
Q4 2022 Feb 13, 2023	BUY	$3.02 - $5.37 $706,571 - $1.26 Million	233,964 Added 227.92%	336,618 $1.77 Million
Q3 2022 Nov 14, 2022	SELL	$2.99 - $4.35 $85,322 - $124,131	-28,536 Reduced 21.75%	102,654 $318,000
Q2 2022 Aug 11, 2022	SELL	$2.67 - $4.77 $45,195 - $80,741	-16,927 Reduced 11.43%	131,190 $500,000
Q1 2022 May 13, 2022	SELL	$2.62 - $4.45 $41,186 - $69,954	-15,720 Reduced 9.59%	148,117 $546,000
Q4 2021 Feb 11, 2022	BUY	$4.05 - $5.37 $28,649 - $37,987	7,074 Added 4.51%	163,837 $716,000
Q3 2021 Nov 04, 2021	SELL	$3.89 - $5.48 $18,041 - $25,416	-4,638 Reduced 2.87%	156,763 $683,000
Q2 2021 Aug 11, 2021	SELL	$3.61 - $5.45 $3.01 Million - $4.55 Million	-834,703 Reduced 83.8%	161,401 $879,000
Q1 2021 May 13, 2021	BUY	$3.14 - $6.14 $2.59 Million - $5.06 Million	824,161 Added 479.32%	996,104 $3.9 Million
Q4 2020 Feb 16, 2021	BUY	$1.79 - $4.04 $78,212 - $176,523	43,694 Added 34.07%	171,943 $539,000
Q3 2020 Nov 12, 2020	BUY	$1.56 - $2.08 $30,178 - $40,237	19,345 Added 17.76%	128,249 $241,000
Q2 2020 Aug 13, 2020	BUY	$0.94 - $2.21 $36,620 - $86,097	38,958 Added 55.7%	108,904 $190,000
Q1 2020 May 14, 2020	SELL	$0.84 - $1.76 $63,637 - $133,335	-75,759 Reduced 51.99%	69,946 $72,000
Q4 2019 Feb 14, 2020	BUY	$1.14 - $1.49 $105,876 - $138,382	92,874 Added 175.79%	145,705 $187,000
Q3 2019 Nov 14, 2019	SELL	$1.04 - $1.44 $9,828 - $13,608	-9,450 Reduced 15.17%	52,831 $65,000
Q2 2019 Aug 14, 2019	SELL	$1.09 - $1.88 $386,982 - $667,456	-355,030 Reduced 85.08%	62,281 $70,000
Q1 2019 May 15, 2019	BUY	$1.14 - $2.25 $284,116 - $560,756	249,225 Added 148.27%	417,311 $820,000
Q4 2018 Feb 14, 2019	SELL	$1.02 - $2.05 $175,198 - $352,114	-171,763 Reduced 50.54%	168,086 $177,000
Q3 2018 Dec 21, 2021	BUY	$1.01 - $2.19 $59,483 - $128,980	58,895 Added 20.96%	339,849 $622,000
Q3 2018 Nov 14, 2018	SELL	$1.01 - $2.19 $26,638 - $57,761	-26,375 Reduced 8.58%	280,954 $513,000
Q2 2018 Apr 21, 2020	BUY	$1.59 - $2.38 $101,028 - $151,225	63,540 Added 26.06%	307,329 $584,000
Q2 2018 Aug 14, 2018	BUY	$1.59 - $2.38 $361,656 - $541,347	227,457 Added 1392.71%	243,789 $463,000
Q1 2018 Oct 18, 2019	BUY	$2.28 - $3.8 $33,306 - $55,510	14,608 Added 847.33%	16,332 $37,000
Q1 2018 May 15, 2018	SELL	$2.28 - $3.8 $414 - $691	-182 Reduced 9.55%	1,724 $3,000
Q4 2017 Feb 14, 2018	BUY	$2.28 - $6.71 $2,975 - $8,756	1,305 Added 217.14%	1,906 $4,000
Q3 2017 Nov 14, 2017	BUY	$1.15 - $2.29 $691 - $1,376	601	601 $1,000

Others Institutions Holding MNKD

# of Institutions

245

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.53B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account